Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xuhanting Granular
- Development stage
- Unknown
- Lead developer
- First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Xuhanting Granular is a Traditional Chinese Medicine (TCM) hospital preparation developed by the First Teaching Hospital of Tianjin University of Traditional Chinese Medicine. It is specifically formulated for the treatment and prevention of recurrent respiratory tract infections (RRTI) in pediatric patients, particularly those diagnosed with Lung-Spleen Qi deficiency. The preparation is based on a traditional formula designed to tonify Qi, strengthen the body's exterior defenses, and stop spontaneous or night sweating (hyperhidrosis), which are often clinical markers of a weakened immune system in TCM theory. Pharmacologically, Xuhanting Granular acts as an immunomodulator; clinical studies have demonstrated its ability to increase serum levels of immunoglobulins (IgA, IgG, and IgM) and regulate T-lymphocyte subsets (increasing CD3+ and CD4+ counts and the CD4+/CD8+ ratio), thereby enhancing the patient's resistance to viral and bacterial respiratory pathogens.
- Brand names
- Xuhanting Granular
- Other names
- Xuhanting Keli虚汗停颗粒
02
Targets
IgA (Immunoglobulin A)
Beyond the preview
Go deeper on Xuhanting Granular.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Xuhanting Granular.